Literature DB >> 8485914

Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.

I J de Messias1, J Santamaria, M Brenden, A Reis, G Mauff.   

Abstract

A considerable number of studies have postulated significant associations between susceptibility to the different clinical manifestations of leprosy and the MHC. In this investigation, the association between the MHC class III complement proteins C2, BF, C4A and C4B and leprosy in a patient population of Southern Brazil was studied. A total of 109 non-related leprosy patients was investigated; 73 presented with lepromatous leprosy (LL), 46 of them had the immunopathological reaction of erythema nodosum (ENL), the remaining 36 were tuberculoid, borderline and indeterminate leprosy (TIBL) patients. The control group included 172 healthy individuals matched with the patients according to their ethnic and geographical origin. C2, BF, C4A and C4B allotypes were determined by standard technologies including Western blots for C2 and C4 variant alleles with monoclonal and polyclonal antibodies. Non-expressed ('silent') C4 alleles in hemizygously deficient individuals were estimated semiquantitatively on the basis of the C4A and C4B isotype ratio and by the MASC ('minimal chi-square') method. The results showed a significantly elevated presence of the non-expressed C4B allele (C4B*Q0) in the LL and ENL patient groups in comparison with the controls. The most significant difference was observed in the ENL group when compared with the controls. In addition, all patients who were homozygously C4B-deficient had ENL, and most of them had the BF*F1 allele. The comparison between LL patients with and without ENL also showed a statistically significant difference in the presence of C4B*Q0, indicating that C4B deficiency itself is associated with ENL. The relative risk of LL patients with the C4B*Q0 allele suffering from ENL was 5.3 compared with LL patients without C4B*Q0. Since immune complexes (IC) are considered to be the pathogenic cause of ENL, our findings indicate that C4B deficiency may play an important role in the abnormal immune response against Mycobacterium leprae and in the lack of IC clearance, leading to ENL reactions. Individuals with this allele seem to be at a higher risk of developing pathological immune reactivity in lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485914      PMCID: PMC1554813          DOI: 10.1111/j.1365-2249.1993.tb03393.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker.

Authors:  W van Eden; R R de Vries; N K Mehra; M C Vaidya; J D'Amaro; J J van Rood
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

2.  The genetic hypothesis for susceptibility to lepromatous leprosy.

Authors:  D G Smith
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 3.  Inherited deficiencies of complement proteins in man.

Authors:  C A Alper; F S Rosen
Journal:  Springer Semin Immunopathol       Date:  1984

Review 4.  The immunology of leprosy: speculations on the leprosy spectrum.

Authors:  P Sansonetti; P H Lagrange
Journal:  Rev Infect Dis       Date:  1981 May-Jun

5.  Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.

Authors:  J Greiner; F J Weber; G Mauff; M Baur
Journal:  Immunobiology       Date:  1980       Impact factor: 3.144

6.  A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.

Authors:  M C Carroll; R D Campbell; D R Bentley; R R Porter
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

Review 8.  Inherited complement deficiencies.

Authors:  P J Lachmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-09-06       Impact factor: 6.237

9.  Association of major histocompatibility complex class III complement components C2, BF, and C4 with Brazilian paracoccidioidomycosis.

Authors:  I J de Messias; A Reis; M Brenden; F Queiroz-Telles; G Mauff
Journal:  Complement Inflamm       Date:  1991

10.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

View more
  9 in total

1.  Susceptibility to leprosy is associated with M-ficolin polymorphisms.

Authors:  Angelica B W Boldt; Maria Iolanda N Sanchez; Ewalda R S Stahlke; Rudi Steffensen; Steffen Thiel; Jens C Jensenius; Flávia Costa Prevedello; Marcelo Távora Mira; Jürgen F J Kun; Iara J T Messias-Reason
Journal:  J Clin Immunol       Date:  2012-09-01       Impact factor: 8.317

2.  Lepromatous leprosy with erythema nodosum leprosum as immune reconstitution inflammatory syndrome in an HIV-1 infected patient after initiation of antiretroviral therapy.

Authors:  Alexia Cusini; Huldrych F Günthard; Rainer Weber; Milo Huber; Jivko Kamarashev; Barbara Bertisch; Silke Peter; Bernhard Beck
Journal:  BMJ Case Rep       Date:  2009-12-01

Review 3.  Leprosy and the human genome.

Authors:  Elizabeth A Misch; William R Berrington; James C Vary; Thomas R Hawn
Journal:  Microbiol Mol Biol Rev       Date:  2010-12       Impact factor: 11.056

4.  Mannan-binding lectin plasma levels in leprosy: deficiency confers protection against the lepromatous but not the tuberculoid forms.

Authors:  L N Dornelles; L Pereira-Ferrari; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

5.  Human polymorphisms as clinical predictors in leprosy.

Authors:  Ernesto Prado Montes de Oca
Journal:  J Trop Med       Date:  2011-12-18

6.  Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase.

Authors:  Henrique J P Gomes; Ricardo L R Souza; Flávia Costa Prevedello; Marcelo Távora Mira; Eleidi A Chautard-Freire-Maia
Journal:  J Trop Med       Date:  2012-02-22

7.  Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

Authors:  Hannele Kotilainen; Marja-Liisa Lokki; Riitta Paakkanen; Mikko Seppänen; Pentti Tukiainen; Seppo Meri; Tuija Poussa; Jussi Eskola; Ville Valtonen; Asko Järvinen
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

Review 8.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

9.  Leprosy association with low MASP-2 levels generated by MASP2 haplotypes and polymorphisms flanking MAp19 exon 5.

Authors:  Angelica Beate Winter Boldt; Isabela Goeldner; Ewalda R S Stahlke; Steffen Thiel; Jens Christian Jensenius; Iara José Taborda de Messias-Reason
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.